Centaurus Financial’s Idexx Laboratories IDXX Stock Holding History

Centaurus Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381K	Sell	723 -2	-0.3%	-$1.12K	0.01%	657
2026 Q1	$407K	Hold	725	–	–	0.02%	585
2025 Q4	$490K	Sell	725 -5	-0.7%	-$3.4K	0.02%	535
2025 Q3	$466K	Sell	730 -24	-3%	-$14.6K	0.02%	554
2025 Q2	$404K	Sell	754 -154	-17%	-$73.6K	0.02%	534
2025 Q1	$381K	Buy	908 +628	+224%	+$273K	0.02%	521
2024 Q4	$116K	Buy	280 +53	+23%	+$23.2K	0.01%	830
2024 Q3	$115K	Buy	+227	New	+$110K	0.01%	788
2022 Q2	–	Sell	-200	Closed	-$109K	–	870
2022 Q1	$109K	Hold	200	–	–	0.01%	845
2021 Q4	$132K	Hold	200	–	–	0.01%	809
2021 Q3	$124K	Buy	+200	New	+$134K	0.01%	794

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Centaurus Financial's IDXX Position: Q2 2026 in Review

Centaurus Financial reduced its Idexx Laboratories (IDXX) stake by 0.28% in Q2 2026, selling an estimated $1.12K and leaving 723 shares worth $381K. The position accounts for 0.01% of the portfolio, ranked #657.

Centaurus Financial first reported a position in IDXX in Q3 2021 and has held it in 11 quarters since. The position peaked at $490K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Centaurus Financial held 723 shares of Idexx Laboratories worth $381K as of Q2 2026.
Centaurus Financial sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
Idexx Laboratories made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #657 holding.
Centaurus Financial first reported a position in Idexx Laboratories in Q3 2021 and has held it in 11 quarters since.
Centaurus Financial's Idexx Laboratories position peaked at $490K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.